Phreesia, Inc. (NYSE: PHR) has reported robust financial results for the fiscal fourth quarter and full year ended January 31 ...

Healthcare technology company Phreesia (NYSE:PHR) in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The ...

Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on ...

Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best ...

Truist Financial analyst Jailendra Singh maintained a Buy rating on Phreesia (PHR – Research Report) today. The company’s shares closed ...

Canaccord raised the firm’s price target on Phreesia (PHR) to $35 from $34 and keeps a Buy rating on the shares. The firm said they remain ...

Phreesia, Inc. (NYSE:PHR – Get Free Report)’s share price shot up 3.9% on Thursday after Canaccord Genuity Group raised their price target on the stock from $34.00 to $35.00. Canaccord Genuity Group ...

Phreesia (NYSE:PHR – Free Report) had its price objective upped by Canaccord Genuity Group from $34.00 to $35.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on ...

Phreesia Inc. (PHR) on Wednesday reported a loss of $6.4 million in its fiscal fourth quarter. The Wilmington, Delaware-based company said it had a ...

Healthcare technology company Phreesia (NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s ...

Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best Healthcare Software Products category. As the world’s largest and ...